CDK9-IN-26

CDK9-IN-26 (compound 1is a CDK9 inhibitor (IC50=0.18 μM) . [1].

Product Specifications

UNSPSC

12352005

Target

CDK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/cdk9-in-26.html

Solubility

10 mM in DMSO

Smiles

COC1=CC=C(NC2=C(C3=COC=C3)N=C4C=NC=CN42)C=C1

Molecular Formula

C17H14N4O2

Molecular Weight

306.32

References & Citations

[1]Alsfouk AA, et al. New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches. Pharmaceuticals (Basel) . 2023 Jul 18;16 (7) :1018.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

SI204512A 1 Each

Rat Ephx4 Pre-designed siRNA Set A

Ask

View Details

NBP2-93174-0.02mL 0.02 mL

Rabbit Polyclonal PISD Antibody

Ask

View Details

GTR15403453 1 Vial

Human IDO1 Knockout HEK293T cell line

Ask

View Details

MBS1354844-01 0.02 mg (E-Coli)

Recombinant Salmonella typhi Pantothenate synthetase (panC)

Ask

View Details

MBS1354844-02 0.02 mg (Yeast)

Recombinant Salmonella typhi Pantothenate synthetase (panC)

Ask

View Details

MBS1354844-03 0.1 mg (E-Coli)

Recombinant Salmonella typhi Pantothenate synthetase (panC)

Ask

View Details